NSE:ASTRAZEN
AstraZeneca Pharma India Limited · NSE · Healthcare · INR · FY for 2026
Figures on this page computed 2026-11-08 12:42 UTC
Last close
n/aINR
Market data
85.0xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- computed
- Computed from the filing for 2026
32.5%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
8.2%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
0.1%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
0.13Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
0.5%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- computed
Price is the furthest below its sector's middle: 0.09 against 0.36 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2026
- Sales2.17x
Its own average over 10 years, 10.48B.
- Profit2.20x
Its own average over 10 years, 850.7M.
- Free cash flow0.09x
Its own average over 10 years, 364.4M.
- Debt4.63x
Its own average over 8 years, 238.8M.
- Pricen/a
Its own average over 0 years. Market data
Debt is furthest from its own average, at 4.63 times.
Sales is 2.17 times its own 10-year average; Profit is 2.20 times its own 10-year average; Free cash flow is 0.09 times its own 10-year average; Debt is 4.63 times its own 8-year average.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2026
Sales against its own 10-year average2.17
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
Profit against its own 10-year average2.20
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
Free cash flow against its own 10-year average0.09
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
Debt against its own 8-year average4.63
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
Price against its own 0-year averagen/aMarket data
Not held.
- Source
- market
- Reported in
- INR